LMO2 and acute lymphoblastic leukemia: Previous studies have shown that LMO2 mutations in the non-coding sites of T-ALL cell lines could result in the formation of abnormal promoters and enhancers, which drive the overexpression of LMO2 in patients with T-ALL [8].